- 8, The Green Suite, 12341 Dover,
DE 19901-3618 - info@immgenuity.com
+1-302-321-5844
Immgenuity Inc.
Applying ingenuity and innovation
to improve lives around the world
About Us
Leadership
Dr. Apte, in his capacity as managing director of Swiss Pacific Group, Ltd., is the founder of Immgenuity Inc.
Dr. Apte specializes in neurology and has an extensive background in research, teaching and consulting in the field of neurological sciences. The similarities neurology and immunology, and his in-depth study in this area, have allowed an easy transport of his medical expertise to the research arena. More recently, as neurological complications of HIV such as HAND and HAD come into focus, Dr Apte's interest has been stimulated by the need for a therapeutic vaccine to restore immune signaling and have the adaptive immune response to reach highly conserved sanctuary regions such as the microgoia and astrocytes in the brain. Antiretrovirals have not been spectacularly effective in addressing neurological complications of HIV. Dr. Apte hypothesizes that restoration of immune signaling would lead to a remission of HIV.
Dr. Apte's professional appointments have included active staff positions at the VA Medical Center in Livermore, CA; ValleyCare Medical Center in Pleasanton, CA, and directorships with PainCare Medical Clinic, and the Sleep Disorders Center in San Ramon and Pleasanton, CA. He served as President and CEO of multi-speciality groups Oak Hill Medical Group (1987-1988), Northern California Physicians Associates, Inc. and Alpha Medical Group, Inc. (1986-1992) and then served as President and CEO of ImmunoScience, Inc until 2019. He has served in numerous professional medical associations and is currently an active member in the American Academy of Neurology, American Public Health Association, International AIDS Society, International Association of Providers of AIDS Care and the American Association for the Advancement of Science. His current consulting appointments include The National Multiple Sclerosis Society (1991-present) and the Epilepsy League of America (1991-Present). His undergraduate studies were conducted in Pune, India and his graduate training included residencies at Haffkine Institute, Bombay, India in ollaboration with The Pasteur Institute; Boston University Medical Center; Harvard Medical School, Boston, MA; and a senior fellowship at Stanford University Medical Center.
Dr. Apte has authored and co-authored a number of articles for medical publications and has several publications pending. He has been awarded several patents for the therapeutic vaccine.
Dr. Apte is a member of the Scientific Advisory Boards of AREV Life Sciences Inc., Neuropathics Inc., Zaaz Therapeutics Inc., Trility Inc., Biostax Corporation, and Innovative MedTech, Inc..
Mr. Nagy is Vice President of Finance and Chief Financial Officer at Immgenuity, Inc.. Prior to this, he has been actively involved with another biotech company, helping to pursue and secure capital funding for the company. He has extensive experience in domestic and international tax; merger and acquisition evaluation and planning; capital acquisition and structuring; strategic planning and business analysis, finance, and operations. He has worked with private placements and public offerings, including SEC compliance and reporting. Prior to coming on board with Immgenuity, Mr. Nagy was President and Managing Director of Meridian Services, Ltd., a boutique public accounting firm providing services in the areas of sophisticated domestic and foreign tax planning and compliance, asset protection strategies, operations and finance. He continues to work in these areas as a partner with a Charleston, SC public accounting firm which Meridian merged into in early 2020.
Throughout his 40 plus year career in finance, he has served as CFO, Owner/Managing Director, Senior Manager and Senior Partner of various private and public companies. He is an active member of the American Institute of CPAs and the South Carolina Association of CPAs, and has been a lecturer and seminar leader for continuing professional education courses with both organizations. He has been a board member of numerous civic organizations, and is active in his church and other civic endeavors. He has been a Certified Public Accountant since 1977. He earned a B.S in Accounting from the University of South Carolina and has over 1,900 hours in various tax, accounting, management and SEC courses.
Mr. DiCandido is a partner in DiCandido and Azechi, LLLP.
Mr. DiCandido has expertise in serving as in-house counsel and in business representation. He has advised clients on formation and structuring of companies, negotiating and drafting investment transactions, shareholder contracts as well as litigating commercial matters in both state and federal court. Bill has served as in-house counsel to a family office owning over 110 buildings in New York City. He has advised local business associations and chambers of commerce and oversaw the some of the most innovative commercial real estate transactions. He has advised business in sectors such as environmental, technology, food and beverage, real estate and construction. Mr. DiCandido stated, “I love representing business of all sizes because they are producing something for others. Naturally, there are always legal hurdles and it’s my job to provide practical solutions, so they can focus on their core business.”